# The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

> **NCT00666536** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 728 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan and amlodipine
- **DRUG:** valsartan and amlodipine

## Key facts

- **NCT ID:** NCT00666536
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2016-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666536, "The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00666536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*